Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
New York Comprehensive Thalassemia Center
Explore this Website
Home
About Us
Toggle About Us menu options
Our Mission
About Thalassemia
Historical Information
Staff Directory
News & Announcements
Toggle News & Announcements menu options
Conferences & Meetings
Media Gallery
Toggle Media Gallery menu options
Photos of the Center
Publications
Research
Newsletters
Our Program
Toggle Our Program menu options
Pediatric
Transition
Adult
For Patients
Toggle For Patients menu options
Benefits Comprehensive Care
Guidelines
Open Clinical Trials
Upcoming Clinical Trials
Other Ongoing Research
For Providers
Toggle For Providers menu options
Benefits Comprehensive Care
Guidelines
Open Clinical Trials
Upcoming Clinical Trials
Webinars
Other Resources
Contact Us
Toggle Contact Us menu options
Email Center
Weill Cornell Connect
Newsletter Sign-Up
COVID-19 UPDATE
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Our Program
For Patients
For Providers
Other Resources
Contact Us
COVID-19 UPDATE
Home
Publications
Publications
Our Mission
About Thalassemia
Historical Information
Staff Directory
News & Announcements
Media Gallery
Publications
Research
Newsletters
Found 19 results
Author
Title
[
Type
]
Year
Filters:
First Letter Of Last Name
is
D
[Clear All Filters]
Journal Article
Al-Samkari H
,
van Beers EJ
,
D Morton H
,
Barcellini W
,
Eber SW
,
Glader B
,
Yaish HM
,
Chonat S
,
Kuo KHM
,
Kollmar N
et al.
. 2020.
Characterization of the severe phenotype of pyruvate kinase deficiency.
.
Am J Hematol.
Grace RF
,
Bianchi P
,
van Beers EJ
,
Eber SW
,
Glader B
,
Yaish HM
,
Despotovic JM
,
Rothman JA
,
Sharma M
,
McNaull MM
et al.
. 2018.
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
.
Blood. 131(20):2183-2192.
Frangoul H
,
Altshuler D
,
M Cappellini D
,
Chen Y-S
,
Domm J
,
Eustace BK
,
Foell J
,
de la Fuente J
,
Grupp S
,
Handgretinger R
et al.
. 2021.
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
.
N Engl J Med. 384(3):252-260.
Frangoul H
,
Altshuler D
,
M Cappellini D
,
Chen Y-S
,
Domm J
,
Eustace BK
,
Foell J
,
de la Fuente J
,
Grupp S
,
Handgretinger R
et al.
. 2021.
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
.
N Engl J Med. 384(3):252-260.
Frangoul H
,
Altshuler D
,
M Cappellini D
,
Chen Y-S
,
Domm J
,
Eustace BK
,
Foell J
,
de la Fuente J
,
Grupp S
,
Handgretinger R
et al.
. 2021.
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
.
N Engl J Med. 384(3):252-260.
Hoshino A
,
Kim HSang
,
Bojmar L
,
Gyan KEnnu
,
Cioffi M
,
Hernandez J
,
Zambirinis CP
,
Rodrigues G
,
Molina H
,
Heissel S
et al.
. 2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
.
Cell. 182(4):1044-1061.e18.
Hoshino A
,
Kim HSang
,
Bojmar L
,
Gyan KEnnu
,
Cioffi M
,
Hernandez J
,
Zambirinis CP
,
Rodrigues G
,
Molina H
,
Heissel S
et al.
. 2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
.
Cell. 182(4):1044-1061.e18.
Hoshino A
,
Kim HSang
,
Bojmar L
,
Gyan KEnnu
,
Cioffi M
,
Hernandez J
,
Zambirinis CP
,
Rodrigues G
,
Molina H
,
Heissel S
et al.
. 2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
.
Cell. 182(4):1044-1061.e18.
Hoshino A
,
Kim HSang
,
Bojmar L
,
Gyan KEnnu
,
Cioffi M
,
Hernandez J
,
Zambirinis CP
,
Rodrigues G
,
Molina H
,
Heissel S
et al.
. 2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
.
Cell. 182(4):1044-1061.e18.
Hoshino A
,
Kim HSang
,
Bojmar L
,
Gyan KEnnu
,
Cioffi M
,
Hernandez J
,
Zambirinis CP
,
Rodrigues G
,
Molina H
,
Heissel S
et al.
. 2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
.
Cell. 182(4):1044-1061.e18.
Hoshino A
,
Kim HSang
,
Bojmar L
,
Gyan KEnnu
,
Cioffi M
,
Hernandez J
,
Zambirinis CP
,
Rodrigues G
,
Molina H
,
Heissel S
et al.
. 2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
.
Cell. 182(4):1044-1061.e18.
Hoshino A
,
Kim HSang
,
Bojmar L
,
Gyan KEnnu
,
Cioffi M
,
Hernandez J
,
Zambirinis CP
,
Rodrigues G
,
Molina H
,
Heissel S
et al.
. 2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
.
Cell. 182(4):1044-1061.e18.
Hoshino A
,
Kim HSang
,
Bojmar L
,
Gyan KEnnu
,
Cioffi M
,
Hernandez J
,
Zambirinis CP
,
Rodrigues G
,
Molina H
,
Heissel S
et al.
. 2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
.
Cell. 182(4):1044-1061.e18.
Hoshino A
,
Kim HSang
,
Bojmar L
,
Gyan KEnnu
,
Cioffi M
,
Hernandez J
,
Zambirinis CP
,
Rodrigues G
,
Molina H
,
Heissel S
et al.
. 2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
.
Cell. 182(4):1044-1061.e18.
van Beers EJ
,
van Straaten S
,
D Morton H
,
Barcellini W
,
Eber SW
,
Glader B
,
Yaish HM
,
Chonat S
,
Kwiatkowski JL
,
Rothman JA
et al.
. 2019.
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.
.
Haematologica. 104(2):e51-e53.
Rapido F
,
Brittenham GM
,
Bandyopadhyay S
,
La Carpia F
,
L'Acqua C
,
McMahon DJ
,
Rebbaa A
,
Wojczyk BS
,
Netterwald J
,
Wang H
et al.
. 2017.
Prolonged Red Cell Storage Before Transfusion Increases Extravascular Hemolysis
.
J Clin Invest. 127(1):375-382.
Jafari R
,
Sheth S
,
Spincemaille P
,
Nguyen TD
,
Prince MR
,
Wen Y
,
Guo Y
,
Deh K
,
Liu Z
,
Margolis D
et al.
. 2019.
Rapid automated liver quantitative susceptibility mapping.
.
J Magn Reson Imaging. 50(3):725-732.
Goss C
,
Giardina P
,
Degtyaryova D
,
Kleinert D
,
Sheth S
,
Cushing M
. 2014.
Red Blood Cell Transfusions for Thalassemia: Results of a Survey Assessing Current Practice and Proposal of Evidence-Based Guidelines
.
Transfusion. 54(7):1773-81.
Badawy SM
,
Kattamis A
,
Ezzat H
,
Deschamps B
,
Sicard E
,
Fradette C
,
Zhao F
,
Tricta F
,
Tsang YChung
,
Sheth S
et al.
. 2022.
The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.
.
Br J Haematol. 197(1):e12-e15.